SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001104659-23-042202
Filing Date
2023-04-05
Accepted
2023-04-05 16:40:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-4 tm239007-1_s4.htm S-4 4851589
2 EXHIBIT 2.2 tm239007d3_ex2-2.htm EX-2.2 15778
3 EXHIBIT 23.1 tm239007d3_ex23-1.htm EX-23.1 1921
4 EXHIBIT 23.2 tm239007d3_ex23-2.htm EX-23.2 2257
5 EXHIBIT 99.1 tm239007d3_ex99-1.htm EX-99.1 4278
6 EXHIBIT 99.2 tm239007d3_ex99-2.htm EX-99.2 5281
7 EX-FILING FEES tm239007d3_ex-filingfees.htm EX-FILING FEES 34517
8 GRAPHIC lg_adaptimmune-4c.jpg GRAPHIC 65407
9 GRAPHIC lg_tcr-4c.jpg GRAPHIC 20631
10 GRAPHIC lg_pipersandler-4c.jpg GRAPHIC 13231
  Complete submission text file 0001104659-23-042202.txt   5053745
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-271145 | Film No.: 23803137
SIC: 2836 Biological Products, (No Diagnostic Substances)